Currently, there are 58.52M common shares owned by the public and among those 53.02M shares have been available to trade.
The company’s stock has a 5-day price change of 28.53% and 34.08% over the past three months. NNOX shares are trading 31.55% year to date (YTD), with the 12-month market performance up to 42.28% higher. It has a 12-month low price of $5.26 and touched a high of $14.28 over the same period. NNOX has an average intraday trading volume of 1.53 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 30.41%, 36.23%, and 7.14% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Nano X Imaging Ltd (NASDAQ: NNOX) shares accounts for 18.25% of the company’s 58.52M shares outstanding.
It has a market capitalization of $626.14M and a beta (3y monthly) value of 2.01. The earnings-per-share (ttm) stands at -$0.86. Price movements for the stock have been influenced by the stock’s volatility, which stands at 15.63% over the week and 10.16% over the month.
Earnings per share for the fiscal year are expected to increase by 15.43%, and 24.82% over the next financial year.
Looking at the support for the NNOX, a number of firms have released research notes about the stock. Alliance Global Partners stated their Buy rating for the stock in a research note on September 08, 2023, with the firm’s price target at $14.50. Cantor Fitzgerald coverage for the Nano X Imaging Ltd (NNOX) stock in a research note released on January 05, 2023 offered a Overweight rating with a price target of $21. Cantor Fitzgerald on their part issued Overweight rating on September 15, 2020.
